# FDA Inspection 1170628 - AcelRx Pharmaceuticals, Inc. - May 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/acelrx-pharmaceuticals-inc/9b80b016-e28a-436b-b1ea-63a553f4e034
Source feed: FDA_Inspections

> FDA Inspection 1170628 for AcelRx Pharmaceuticals, Inc. on May 18, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170628
- Company Name: AcelRx Pharmaceuticals, Inc.
- Inspection Date: 2022-05-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1117803 - 2020-02-13](https://www.keypedia.com/records/fda_inspections/acelrx-pharmaceuticals-inc/43c68861-823b-491c-9b1d-a04bff671f50)
- [FDA Inspection 883185 - 2014-06-30](https://www.keypedia.com/records/fda_inspections/acelrx-pharmaceuticals-inc/921d71a7-de24-4abd-8b03-69a0c4596972)
- [FDA Inspection 883185 - 2014-06-30](https://www.keypedia.com/records/fda_inspections/acelrx-pharmaceuticals-inc/d3c8757a-3d00-4e33-be8f-533a0c8e8828)

Company: https://www.keypedia.com/companies/acelrx-pharmaceuticals-inc/b1ee7b0c-67a2-4336-abe8-b6953cbb5891

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c